There were significant statistical associations between COX-2 over-expression and grade, type II tumours or high-grade serous tumours but not with age indicating that it may influence outcomes and prevention of EOCs with possible variation in tumour type and grade. This evidence concerns the gene PTGS2 and neoplasm.